GLP-1 Weight Loss in Las Vegas: The Complete 2026 Guide
GLP-1 medications have changed what is realistically possible in medical weight loss. If you live in Las Vegas and you are weighing options like semaglutide or tirzepatide, this guide covers what they are, how much weight people actually lose, what they cost, and how Medicare coverage works in Nevada in 2026. It is written and reviewed by Peter DeBry, MD, Medical Director at Vitality Weight Loss.
What is a GLP-1 medication?
GLP-1 receptor agonists are prescription medications that mimic a natural gut hormone (glucagon-like peptide-1) to slow digestion, reduce appetite, and improve how the body handles blood sugar. The two most widely used for weight loss are semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound). Tirzepatide is a dual GIP/GLP-1 agonist, which is part of why it tends to produce greater weight loss in trials.
How much weight can you lose on a GLP-1?
The clinical trial data is strong. In the STEP 1 trial, adults taking once-weekly semaglutide lost about 15% of body weight on average over 68 weeks.[1] In the SURMOUNT-1 trial, tirzepatide produced roughly 20 to 22% body-weight loss at the highest dose.[2] Real-world results vary with dose, nutrition, activity, and consistency, which is why physician supervision and a plan matter as much as the medication itself.
Semaglutide vs tirzepatide vs oral: which is right for you?
At Vitality, all three are prescribed individually after a medical review by Dr. DeBry. Here is how they compare:
| Option | Form | Typical loss* | Vitality price |
|---|---|---|---|
| Compounded semaglutide | Weekly injection | ~15% | $145 first mo · $199/mo |
| Compounded tirzepatide | Weekly injection | ~20% | $249 first mo · $399/mo |
| Oral semaglutide | Daily, no needle | Varies | $199 first mo · $299/mo |
*Typical loss figures reflect published clinical-trial averages, not a guarantee of individual results.
Is a GLP-1 covered by Medicare in Nevada?
Historically, Medicare Part D did not cover medications prescribed solely for weight loss. That is changing, and it is the reason Vitality built the GLP-1 Bridge: a program that helps eligible Medicare members access brand-name Wegovy or Zepbound for about $50 per month instead of $1,000 or more. Eligibility is confirmed by the clinic based on your Medicare plan and medical history. If you are on Medicare and have been told a GLP-1 is out of reach, this is worth a conversation.
How much does GLP-1 weight loss cost in Las Vegas?
At Vitality, compounded semaglutide starts at $145 the first month, then $199 per month, and your price does not increase as your dose increases. Tirzepatide and the no-needle oral option are priced above. For Medicare-eligible patients, the GLP-1 Bridge brings brand-name medication down to roughly $50 per month. Pricing includes physician review and the Vitality program, not just the medication.
Who is a candidate, and who is not?
GLP-1 therapy at Vitality is for Nevada residents aged 18 to 80. A medical screen rules out conditions where a GLP-1 is not appropriate, including a personal or family history of medullary thyroid carcinoma or MEN-2, active pancreatitis, and pregnancy. A short intake captures your history, and Dr. DeBry reviews every case before prescribing. If you are not a candidate for medication, the clinic offers other paths, because not everyone needs a prescription to make progress.
How to get started at Vitality
The process is simple: complete a 3-minute medical intake, Dr. DeBry reviews it within 24 hours, and if approved, your prescription is filled and shipped. You track progress, message your care team, and request refills from your patient portal. There is no charge until you send your request to the doctor.
Frequently asked questions
How much weight can you lose on a GLP-1?
In trials, semaglutide averaged about 15% body-weight loss and tirzepatide about 20 to 22% at the highest dose. Individual results vary.
Is there a GLP-1 option without injections?
Yes. Vitality offers a daily oral, sublingual semaglutide, a true no-needle option, alongside the weekly injections.
Who is the prescribing doctor?
Peter DeBry, MD, a Nevada-licensed physician (NPI 1831137991), medically reviews every patient before any prescription.
References
- [1] Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021. nejm.org
- [2] Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022. nejm.org
- [3] U.S. Food & Drug Administration. Drug approval information for semaglutide and tirzepatide. fda.gov
Peter DeBry, MD is the Medical Director of Vitality Weight Loss in Las Vegas, Nevada (NPI 1831137991). He reviews and prescribes for every patient and oversees the clinic's GLP-1 and Medicare Bridge programs. This guide is for general education and is not a substitute for individual medical advice.
See what you qualify for in 3 minutes.
Complete your intake. Dr. DeBry reviews it within 24 hours. No charge until you request your prescription.
Start your intake →